Putting Patients First
Learn more about how we are working to discover and develop innovative medicines that are more accessible and affordable to patients around the world.
We are advancing an innovative, high-value product portfolio for patients globally.
Passion with Purpose
We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.
Our Commitment to Patients
We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”
November 29, 2023
BeiGene to Host ASH Investor Meeting in Person and via Webcast on December 10, 2023Read more
November 28, 2023
BeiGene to Present New Data Highlighting Hematology Portfolio and Pipeline Strengths at ASH 2023Read more
November 21, 2023
BeiGene and Ensem Therapeutics Announce Partnership to Advance Differentiated CDK2 InhibitorRead more
November 17, 2023
BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Relapsed or Refractory Follicular LymphomaRead more
November 9, 2023